• Contact
• About APA
• Site Map

• Psychiatric Practice
  • Addiction Psychiatry
  • Ethics
  • Managing Your Practice
  • Medicare Medicaid
  • Practice Guidelines
  • Quality Improvement
• Education & Career Development
  • Lifelong Learning & CME
  • Meetings
  • Residents
  • Medical Students
  • Educational Initiatives
  • Melvin Sabshin Library & Archives
• Research
  • DSM
  • International Programs
  • Psychiatric Research Report
  • Health Policy Analysis
  • APIRE
  • Practice Research Network and Health Services Research
  • Research Training and Funding
  • Research in Residency
  • Research Colloquium for Junior Investigators
  • Endowment Campaign
• Advocacy
  • APA AMA Delegation
  • Communications & Public Affairs
  • Financing Health Care
  • Government Relations
  • Political Action Committee
• Newsroom
  • Annual Meeting Newsroom
  • Social Media
  • Annual Reports
  • APA Member and DB/SA Resources
  • APA Daily Bulletin
  • News Releases
• Members Corner

• Home
• Research
• DSM
• DSM-5
• Meet the Task Force
• Kraemer

Helena C. Kraemer, Ph.D.

Name, Degree:  Helena Chmura Kraemer, Ph.D.
Role(s) in Task Force and Work Group:  Task Force Member
Institutional Affiliation(s):  Stanford University (Emerita)
City, State:  Palo Alto, CA

Biographical Sketch:

Dr. Kraemer received her bachelor’s degree in Mathematics from Smith College (Summa cum Laude, 1958), did her first year of graduate study in Statistics as a Fulbright scholar at the University of Manchester, England, and then completed her doctoral studies in the Department of Statistics, Stanford University (1963).  She joined the Department of Psychiatry and Behavioral Sciences at Stanford in 1964.  Her primary interests concern the applications of biostatistics in the behavioral areas of medicine.  In 1964, that seemed largely concentrated in psychiatry, but in the years since, she has worked in Cardiology, Pediatrics, Radiology, Oncology etc., as behavioral issues have become more prominent in all areas of medicine.  She is a Fellow of the American Statistical Association, and of the American College of Neuspychopharmacology.  She was elected a member of the Institute of Medicine, Academy of Sciences, in 2003.  She was also the recipient of the Harvard Prize in Psychiatric Biostatistics and Epidemiology in 2001.   She has published more than 300 papers in peer-reviewed journals, and 3 books.  She has served as associate editor or on the editorial boards of Statistics in Medicine, Psychological Methods, Archives of General Psychiatry, Journal of Child and Adolescent Psychopharmacology.  Her major recent research interests concern the use of statistical methods in risk research, specifically the focus on moderators and mediators, the use of effect sizes to indicate clinical or practical significance to replace the overuse and abuse of statistical significance, and, in general, identifying and trying to rectify common problems in the application of statistical methods in medicine.  She became Emerita in 2007, but continues to be active, serving on the NIMH Council, on the DSM V Task Force, as well as consulting at various universities.

Uncompensated affiliations with non-profit or advocacy organizations that may have a direct or indirect interest in psychiatric diagnosis, treatment, or the DSM-V :   Three calendar years before  nomination and Each year thereafter through the present calendar year.  (For 2008, activities to date and commitments for remainder of year.)

The two tables below represent Dr. Kraemer’s disclosure of significant interests and affiliations for:  (1) The time period including the 3 years prior to nomination to serve on the DSM-V Task Force; the calendar year in which nomination to the Task Force occurred; through the calendar year in which the nomination was approved; and (2) the time period including the calendar year after approval, and each successive year to the present. 

Dr. Kraemer has agreed that, from the time of approval through the publication of DSM-V, projected in 2012, (his/her) aggregate annual income derived from industry sources (excluding unrestricted research grants) will not exceed $10,000 in any calendar year.

Disclosure of significant interests including:  Three (3) calendar years before nomination, the calendar year of nomination, through the calendar year of approval to serve on the DSM-V Task Force

Disclosure of significant interests Beginning with the calendar year after APA Board of Trustees approval to serve on  the DSM-V Task Force, to the present.  (For 2008, activities to date and commitments for remainder of year.)